
{
    "Variants Include": [
        {
            "Gene": "SNCA",
            "variants": [
                {
                    "HGVS": "NM_000345.4:c.89G>A",
                    "cDNA Change": {
                        "transcript": "NM_000345.4",
                        "ref": "G",
                        "alt": "A",
                        "position": "89"
                    },
                    "Protein Change": {
                        "ref": "A",
                        "alt": "P",
                        "position": "30"
                    },
                    "Description in input context": "A30P"
                }
            ]
        }
    ],
    "Described Disease": {
        "Described Disease": "Parkinson disease",
        "MONDO": "MONDO:0005180"
    },
    "Experiment Method": [
        {
            "Assay Method": "Fibrillization Assay",
            "Material used": {
                "Material Source": "Protein",
                "Material Name": "Wild-type and mutant alpha-synuclein",
                "Description": "Purified WT and mutant alpha-synuclein (1 mg/ml) were each incubated at 37 °C, with shaking at 200 rpm in 30 mM Tris-HCl, pH 7.5, containing 0.1% NaN3."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "The A30P mutant accelerates nucleation-dependent fibrillization of wild type alpha-synuclein when acting as seeds. WT α-synuclein incubated with A30P seeds showed faster fibrillization than with WT, E46K, or A53T seeds, with half-maximal fibrillization time of 1.5 days (WT: 2.5 days; E46K: >6 days; A53T: 6 days)."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Results are expressed as means ± S.E. (n=3)"
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT α-synuclein seeds"
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "No seeds added"
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "unpaired Student's t test"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Electron Microscopy (EM) and Ultracentrifugation",
            "Material used": {
                "Material Source": "Protein",
                "Material Name": "Wild-type and mutant alpha-synuclein fibrils",
                "Description": "A30P fibrils and WT fibrils were analyzed by EM after ultracentrifugation. A30P seeds showed more short fibril fragments in supernatants compared to WT, E46K, and A53T seeds."
            },
            "Readout type": "Qualitative and Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "A30P fibrils exhibit higher fragment shedding, with more short fibrils (<100 nm) in supernatants after ultracentrifugation compared to WT. These fragments act as effective seeds to accelerate fibrillization."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Results were confirmed in multiple experiments (e.g., Fig. 2, Fig. 3)"
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "A53T/E46K mutant α-synuclein fibrils (showing less fragment shedding)"
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "WT α-synuclein fibrils"
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "unpaired Student's t test (for quantitative ultracentrifugation data)"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Immunochemical Analysis (Dot Blot Assay)",
            "Material used": {
                "Material Source": "Protein",
                "Material Name": "Wild-type and mutant alpha-synuclein fibrils",
                "Description": "Dot blot assay with epitope-specific antibodies (syn1–10, syn75–91, syn131–140) to detect conformational differences in N-terminal, NAC, and C-terminal regions."
            },
            "Readout type": "Qualitative and Semi-quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "A30P fibrils show distinct conformation: stronger binding to N-terminal antibody (syn1–10), weaker binding to NAC antibody (syn75–91), compared to WT. WT fibrils formed with A30P seeds adopt A30P-like conformation."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Similar results obtained in three separate experiments (Fig. 4, Fig. 7)"
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT α-synuclein fibrils (known conformation)"
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "α-synuclein monomers (weak antibody binding)"
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "unpaired Student's t test (for quantitative immunoreactivity)"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Protease-resistant Core Analysis",
            "Material used": {
                "Material Source": "Protein",
                "Material Name": "Wild-type and mutant alpha-synuclein fibrils",
                "Description": "Fibrils treated with trypsin or proteinase K, followed by SDS-PAGE to analyze protease-resistant fragments."
            },
            "Readout type": "Qualitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "A30P fibrils and WT fibrils formed with A30P seeds show distinct protease-resistant cores (smaller fragments: 9.5 kDa and 12.5 kDa) compared to WT fibrils (10 kDa and 13 kDa), indicating different core structures."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Similar results obtained in three separate experiments (Fig. 5)"
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "WT α-synuclein fibrils (known protease-resistant pattern)"
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "α-synuclein monomers (completely digested by proteases)"
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "N.D."
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        },
        {
            "Assay Method": "Cytotoxicity Assay (MTT Reduction)",
            "Material used": {
                "Material Source": "Protein",
                "Material Name": "Wild-type and mutant alpha-synuclein fibrils (suspended or sonicated)",
                "Description": "SH-SY5Y cells treated with α-synuclein monomers, fibrils, or fibril fragments; cellular redox activity measured by MTT assay."
            },
            "Readout type": "Quantitative",
            "Readout description": [
                {
                    "Variant": "NM_000345.4:c.89G>A",
                    "Conclusion": "Abnormal",
                    "Molecular Effect": "gain-of-function",
                    "Result Description": "A30P fibrils exhibit stronger cytotoxicity than WT or other mutants. Sonication-induced fragmentation enhances cytotoxicity, with A30P-derived fragments showing the highest toxicity."
                }
            ],
            "Biological replicates": {
                "Biological replicates": "Yes",
                "Description": "Results are expressed as means ± S.E. (n=3)"
            },
            "Technical replicates": {
                "Technical replicates": "N.D.",
                "Description": "N.D."
            },
            "Basic positive control": {
                "Basic positive control": "Yes",
                "Description": "Sonicated WT α-synuclein fibrils (positive for cytotoxicity)"
            },
            "Basic negative control": {
                "Basic negative control": "Yes",
                "Description": "α-synuclein monomers (no cytotoxicity)"
            },
            "Validation controls P/LP": {
                "Validation controls P/LP": "N.D.",
                "Counts": "N.D."
            },
            "Validation controls B/LB": {
                "Validation controls B/LB": "N.D.",
                "Counts": "N.D."
            },
            "Statistical analysis method": {
                "Statistical analysis method": "unpaired Student's t test"
            },
            "Threshold for normal readout": {
                "Threshold for normal readout": "N.D.",
                "Source": "N.D."
            },
            "Threshold for abnormal readout": {
                "Threshold for abnormal readout": "N.D.",
                "Source": "N.D."
            },
            "Approved assay": {
                "Approved assay": "Yes"
            }
        }
    ]
}